Ethyl 4-(3-methoxyphenyl)thiazole-2-carboxylate, 95.0%, 100mg

6-Pyrazol-1-yl-pyridin-3-ylamine, 1g

3-Benzoimidazol-1-yl-propionic acid, 95.0%, 1g

(S)-Ethyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate, 95.0%, 25g

9-Chloro-5,6,7,8-tetrahydroacridine-3-carboxylic acid, 95.0%, 50mg

3-Ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, 95.0%, 25g

Methyl-2-bromo-4,5-dimethoxybenzoate, 97.0%, 5g

2,2-Dimethyl-1-oxa-8-azaspiro[4.5]decane hydrochloride, 98%, 250mg

4-(5-Methyl-2-thienyl)-4-oxobutyric acid, 95.0%, 100mg

Inoculation loop holder ROTILABO® 1 piece

N1-(5-Chloropyridin-2-yl)-N2-((1R,2S,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide, 98%, 25mg

Citric acid monohydrate, min. 99.5%, Ph.Eur., 2.5 kg, plastic packaging.

2-chloroacrylic acid, 98% +(stabilized with 0.3-0.5% BHT), 10g